MRS. SARA ELISABETH STEVENS NP
Prescription History 1578901708
Nurse Practitioner - Adult Health in Boston, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MRS. SARA ELISABETH STEVENS NP, an active Adult Health specialist practicing in Boston, MA. Our medical registry currently tracks 18 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 390 documented patient claims. Among these therapy options, the most frequently utilized medication is Tagrisso, which accounts for 58 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| TagrissoOsimertinib Mesylate | 58 | $16,488.81▼ below MA avg | ▲ More than typical |
About Tagrisso: This medication is used to treat lung cancer. Show more ▾ Osimertinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors. An EGFR tyrosine kinase inhibitor. In 2024, this provider wrote 58 Medicare prescriptions for Tagrisso, about 1.9 times the volume of the typical Massachusetts prescriber of this medication (31.2). Medicare paid an average of $16,488.81 per fill, versus $16,590.39 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 58 30-Day Fills standardized to 30-day supplies 1,740 Days of Medication total across all patients in 2024 | |||
| Dexamethasone | 57 | $8.58▼ below MA avg | ▲ More than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2024, this provider wrote 57 Medicare prescriptions for Dexamethasone, about 2.1 times the volume of the typical Massachusetts prescriber of this medication (27.6). Medicare paid an average of $8.58 per fill, versus $12.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 59 30-Day Fills standardized to 30-day supplies 673 Days of Medication total across all patients in 2024 | |||
| Prochlorperazine Maleate | 38 | $13.83▼ below MA avg | ▲ More than typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2024, this provider wrote 38 Medicare prescriptions for Prochlorperazine Maleate, about 1.4 times the volume of the typical Massachusetts prescriber of this medication (27). Medicare paid an average of $13.83 per fill, versus $13.98 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 38 30-Day Fills standardized to 30-day supplies 460 Days of Medication total across all patients in 2024 | |||
| Ondansetron Hcl | 27 | $11.68▼ below MA avg | ≈ Typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 27 Medicare prescriptions for Ondansetron Hcl, about the same volume as the typical Massachusetts prescriber of this medication (26.9). Medicare paid an average of $11.68 per fill, versus $13.94 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 27 30-Day Fills standardized to 30-day supplies 380 Days of Medication total across all patients in 2024 | |||
| Oxycodone Hcl | 24 | $11.55▼ below MA avg | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 24 Medicare prescriptions for Oxycodone Hcl, about half the volume of the typical Massachusetts prescriber of this medication (44.8). Medicare paid an average of $11.55 per fill, versus $12.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 24 30-Day Fills standardized to 30-day supplies 423 Days of Medication total across all patients in 2024 | |||
| LorbrenaLorlatinib | 20 | $20,884.51 | ≈ Typical |
About Lorbrena: Lorlatinib is used to treat a certain type of lung cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Inhibits both anaplastic lymphoma kinase and c-ros oncogene 1 (ROS1) protein. In 2024, this provider wrote 20 Medicare prescriptions for Lorbrena, about the same volume as the typical Massachusetts prescriber of this medication (18.3). Medicare paid an average of $20,884.51 per fill, versus $19,687.39 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| Prednisone | 20 | $2.77▼ below MA avg | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 20 Medicare prescriptions for Prednisone, about half the volume of the typical Massachusetts prescriber of this medication (44.4). Medicare paid an average of $2.77 per fill, versus $4.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 20.3 30-Day Fills standardized to 30-day supplies 359 Days of Medication total across all patients in 2024 | |||
| Omeprazole | 18 | $6.08▼ below MA avg | ▼ Less than typical |
About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾ It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. In 2024, this provider wrote 18 Medicare prescriptions for Omeprazole, about 19% of the volume of the typical Massachusetts prescriber of this medication (97.3). Medicare paid an average of $6.08 per fill, versus $15.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2024 | |||
| EliquisApixaban | 16 | $795.36▼ below MA avg | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent. In 2024, this provider wrote 16 Medicare prescriptions for Eliquis, about 18% of the volume of the typical Massachusetts prescriber of this medication (87.7). Medicare paid an average of $795.36 per fill, versus $852.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 22 30-Day Fills standardized to 30-day supplies 658 Days of Medication total across all patients in 2024 | |||
| Nystatin | 15 | $18.46 | ▼ Less than typical |
About Nystatin: Nystatin is used to treat fungal skin infections. Show more ▾ Nystatin is an antifungal that works by stopping the growth of fungus. Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. In 2024, this provider wrote 15 Medicare prescriptions for Nystatin, about 63% of the volume of the typical Massachusetts prescriber of this medication (23.7). Medicare paid an average of $18.46 per fill, versus $18.05 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 377 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 13 | $12.65▼ below MA avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 13 Medicare prescriptions for Gabapentin, about 16% of the volume of the typical Massachusetts prescriber of this medication (80.5). Medicare paid an average of $12.65 per fill, versus $14.49 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 19 30-Day Fills standardized to 30-day supplies 550 Days of Medication total across all patients in 2024 | |||
| XalkoriCrizotinib | 13 | $12,296.83▼ below MA avg | ≈ Typical |
About Xalkori: Crizotinib is used to treat certain types of cancer (such as lung cancer, anaplastic large cell lymphoma-ALCL). Show more ▾ It is also used to treat a certain type of tumor (inflammatory myofibroblastic tumor-IMT). Crizotinib works by slowing or stopping the growth of cancer or tumor cells. It belongs to a class of drugs known as kinase inhibitors. A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER. In 2024, this provider wrote 13 Medicare prescriptions for Xalkori, about the same volume as the typical Massachusetts prescriber of this medication (14.2). Medicare paid an average of $12,296.83 per fill, versus $16,985.91 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
| Trazodone Hcl | 12 | $2.06▼ below MA avg | ▼ Less than typical |
About Trazodone Hcl: This medication is used to treat depression. Show more ▾ Trazodone works by helping to restore the balance of a certain natural substance (serotonin) in the brain. A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309) In 2024, this provider wrote 12 Medicare prescriptions for Trazodone Hcl, about 17% of the volume of the typical Massachusetts prescriber of this medication (72.5). Medicare paid an average of $2.06 per fill, versus $9.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 13 30-Day Fills standardized to 30-day supplies 374 Days of Medication total across all patients in 2024 | |||
| AlecensaAlectinib Hcl | 12 | $19,156.86 | ▼ Less than typical |
About Alecensa: Alectinib is used to treat a certain type of lung cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Alectinib belongs to a class of drugs known as tyrosine kinase inhibitors. An ANAPLASTIC LYMPHOMA KINASE (Alk) inhibitor. In 2024, this provider wrote 12 Medicare prescriptions for Alecensa, about 63% of the volume of the typical Massachusetts prescriber of this medication (19). Medicare paid an average of $19,156.86 per fill, versus $15,486.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| TabrectaCapmatinib Hydrochloride | 12 | $17,487.02▼ below MA avg | ≈ Typical |
About Tabrecta: This medication is used to treat a certain type of lung cancer (non-small cell lung cancer-NSCLC). Show more ▾ Capmatinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. A c-Met inhibitor. In 2024, this provider wrote 12 Medicare prescriptions for Tabrecta, about 79% of the volume of the typical Massachusetts prescriber of this medication (15.1). Medicare paid an average of $17,487.02 per fill, versus $19,051.96 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 12 30-Day Fills standardized to 30-day supplies 336 Days of Medication total across all patients in 2024 | |||
| RetevmoSelpercatinib | 12 | $22,810.93 | ▼ Less than typical |
About Retevmo: This medication is used to treat certain types of cancer (such as lung cancer, thyroid cancer, medullary thyroid cancer, certain other solid tumors). Show more ▾ Selpercatinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Selective RET inhibitor. In 2024, this provider wrote 12 Medicare prescriptions for Retevmo, about 70% of the volume of the typical Massachusetts prescriber of this medication (17.3). Medicare paid an average of $22,810.93 per fill, versus $16,826.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Lorazepam | 12 | $1.88▼ below MA avg | ▼ Less than typical |
About Lorazepam: This medication is used to treat anxiety. Show more ▾ Lorazepam belongs to a class of drugs known as benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA). A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. In 2024, this provider wrote 12 Medicare prescriptions for Lorazepam, about a quarter of the volume of the typical Massachusetts prescriber of this medication (59.7). Medicare paid an average of $1.88 per fill, versus $6.11 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 12 30-Day Fills standardized to 30-day supplies 233 Days of Medication total across all patients in 2024 | |||
| XareltoRivaroxaban | 11 | $1,021.54 | ▼ Less than typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2024, this provider wrote 11 Medicare prescriptions for Xarelto, about a quarter of the volume of the typical Massachusetts prescriber of this medication (41). Medicare paid an average of $1,021.54 per fill, versus $942.73 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MRS. SARA ELISABETH STEVENS NP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Adult Health prescribing approach at this Boston, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
